Biocytogen
Biocytogen is a biotechnology company headquartered in Beijing developing antibody drug discovery solutions based on gene editing and animal model studies.
4
Funding Rounds
$284.4m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Yu**** Sh** | - | - |
Funding
Funding series
Funding Series Analysis
The company Biocytogen has raised a total of $142.4m in funding over 4 rounds.
Key Insights:
- Biocytogen Series D round, August 2019: $79m
- Beijing Biocytogen Co., Ltd. Series C round, April 10, 2018: $63.4m
- Biocytogen Series D round(extension), September 2020: $142m
Biocytogen Series D round, August 2019
$79m
Beijing Biocytogen Co., Ltd. Series C round, April 10, 2018
$63.4m
Biocytogen Series D round(extension), September 2020
$142m
Industries
Biocytogen is active in the following industries:
- Biotechnology
- Healthcare
- Biomedical engineering
- Genetics
- Genomics
- Antibody
- Immunology
- Technology
- Biology
- Internal medicine
- Medicine
- Genome editing
- Engineering